More Please® Multiorgasm Pill Cabergoline, Oral
Why are multiple orgasms elusive to some people? The cause is the hormone prolactin. In some women, it is elevated to prevent orgasm. In all men, it is released after the first orgasm stopping another erection. Damn prolactin – I wish I was lackin!
This Vie prescription medicine blocks the prolactin to enable a second orgasm.
- blocks prolactin – this is what inhibits another pop
- cabergoline is the active ingredient
- not a daily medicine, but taken the day of sexual encounter
- Vie has the dosing instructions
- for men and women
- usage protocols are sent on receipt of order
We Also Recommend for You
Sildenafil + The Love Hormone® Oxytocin and Sexy Gum®, Oral$60.00 Select options
Tadalafil + The Love Hormone® Oxytocin, Oral$60.00 Select options
More Please® Multiorgasm Pill Cabergoline, Oral$96.00 Select options
Herpes Blocker® Valcyclovir (500 mg tablets), Oral$30.00 Add to cart
Screem Creem® (30 grams = 30 cc)$50.00 Select options
Malibu Pill® Melanotan I Injectable/Nasal Spray (5 ml = at least 50 doses)$220.00 Read more
PT-141 (10,000 mcg/ml), Injectable$240.00 Add to cart
Pink Again® Anal Bleach, Topical$66.00 Select options
Period Blocker®, Oral$90.00 Select options
DHEA (100 mg), Micronized Capsule$42.00 – $126.00 Select options
The Love Hormone® – Oxytocin intranasal (5 ml = 50 sprays)$75.00 Add to cart
Make Me Wet® Estrogen (5 mg estradiol) Vaginal dissolving troche (24 doses)$50.00 Select options
notes: More Please® is a pill that has been shown to allow a man to have multiple orgasms. For women, they must have prolactin excess for this pill to work for them. It works by blocking prolactin – the hormone released after male orgasm that inhibits a second erection. Usually, it is taken the night before its effects are desired. It has a half-life of 69 hours. Sometimes this medicine is used to combat Parkinson’s disease symptoms by stimulating D2 dopamine receptors. It is not used in patients with uncontrolled hypertension.
Effects of acute prolactin manipulation on sexual drive and function in males.notes: More Please® is a pill that has been shown to allow a man to have multiple orgasms. For women, they must have prolactin excess for this pill to work for them. It works by blocking prolactin – the hormone released after male orgasm that inhibits a second erection. Usually, it is taken the night before its effects are desired. It has a half-life of 69 hours. Sometimes this medicine is used to combat Parkinson’s disease symptoms by stimulating D2 dopamine receptors. It is not used in patients with uncontrolled hypertension.
Effects of acute prolactin manipulation on sexual drive and function in males.
Krüger TH1, Haake P, Haverkamp J, Krämer M, Exton MS, Saller B, Leygraf N, Hartmann U, Schedlowski M.
Department of Medical Psychology, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany. email@example.com
The neuroendocrine response to sexual activity in humans is characterized by a pronounced orgasm-dependent increase of plasma levels of prolactin. In contrast to the well-known inhibitory effects of chronic hyperprolactinemia on sexual drive and function, the impact of acute prolactin alterations on human sexual physiology is unknown. Therefore, this study was designed to investigate the effects of acute manipulation of plasma prolactin on sexual behavior. Ten healthy males participated in a single-blind, placebo-controlled, balanced cross-over design. Prolactin levels were pharmacologically increased to high levels (protirelin, 50 micro g i.v.) or reduced to low physiological concentrations (cabergoline, 0.5 mg p.o.). Sexual arousal and orgasm were then induced by an erotic film and masturbation. In addition to continuous neuroendocrine and cardiovascular recordings, the quality and intensity of the acute sexual drive, arousal, orgasm and refractory period were assessed by extensive psychometric measures. Administration of cabergoline decreased prolactin levels and significantly enhanced all parameters of sexual drive (P<0.05), function (P<0.01) and positive perception of the refractory period (P<0.01). Administration of protirelin increased prolactin concentrations and produced small, but not significant reductions of sexual parameters. The sexual effects observed from cabergoline were completely abrogated by coadministration of protirelin. Although different pharmacological sites of action of prolactin-altering drugs have to be considered, these data demonstrate that acute changes in prolactin plasma levels may be one factor modulating sexual drive and function. Therefore, besides a neuroendocrine reproductive reflex, a post-orgasmic prolactin increase may represent one factor modulating central nervous system centers controlling sexual drive and behavior. These findings may offer a new pharmacological approach for the treatment of sexual disorders